TCGA-TCIA Impact on Radiogenomics Cancer Research: A Systematic Review

Mario Zanfardino1, Katia Pane1, Peppino Mirabelli1

  • 1IRCCS SDN, Via E. Gianturco, 113, 80143 Naples, Italy.

Insights

Radiogenomics research links imaging features to molecular data, overcoming patient number limitations using The Cancer Genome Atlas (TCGA) and The Cancer Imaging Archive (TCIA). This review analyzes these studies for improved cancer diagnosis and outcomes.

Area of Science:

  • Oncology
  • Radiology
  • Genomics
  • Bioinformatics

Background:

  • Radiogenomics research correlates imaging features with molecular signatures from next-generation sequencing.
  • Many studies are limited by small patient cohorts.
  • The Cancer Genome Atlas (TCGA) and The Cancer Imaging Archive (TCIA) provide crucial linked molecular and imaging data.

Purpose of the Study:

  • To systematically review radiogenomic studies utilizing TCGA and TCIA data.
  • To organize findings by tumor type and molecular data.
  • To discuss key imaging-genomic associations, study limitations, and clinical impact.

Main Methods:

  • Systematic literature collection and analysis of radiogenomic studies.
  • Data organization based on tumor type and molecular omics signatures.
  • Review focused on studies leveraging TCGA and TCIA datasets.

Main Results:

  • Identified numerous imaging-genomic associations across various tumor types.
  • Highlighted limitations such as data heterogeneity and cohort size.
  • Demonstrated the value of TCGA-TCIA resources in advancing radiogenomics.

Conclusions:

  • Radiogenomics, powered by large datasets like TCGA-TCIA, shows significant potential for integrated diagnostics.
  • Improved accuracy in cancer diagnosis and patient outcome prediction is achievable.
  • Further research is needed to overcome existing limitations and enhance clinical translation.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K